July 26, 2022

OASAS has published the OASAS Medical Advisory Panel’s (MAP’s) Review of the Evidence on Low and High Dose Buprenorphine Initiation for the Treatment of Opioid Use Disorder on our website: https://oasas.ny.gov/lowhigh-dose-buprenorphine. 

Attached are sample protocols and additional resources for outpatient low dose buprenorphine inductions.

Please contact AddictionMedicine@oasas.ny.gov with any questions. Thanks.